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Introduction: Concurrent iliac occlusion and abdominal aortic aneurysm is rare. Traditionally, the endovascular approach
to these patients has consisted of aortouniiliac devices combined with femoral–femoral bypass. With improved facility of
endovascular techniques, standard bifurcated endografts represent an alternative option in these patients. This study
examined outcomes of patients undergoing iliac recanalization and traditional bifurcated endovascular aneurysm repair
in the face of access vessel occlusion.
Methods: Outcomes of patients at three academic tertiary referral centers who underwent attempted iliac recanalization of
chronic iliac occlusions and concurrent endovascular aneurysm repair of an infrarenal aortic aneurysm were retrospec-
tively reviewed. Patients with acute iliac thrombosis and those with severely stenotic (but patent) iliac vessels were
excluded.
Results: During a 6-year period, 15 occluded iliac arteries were treated in 14 patients (13 men). Mean age was 67.8 years
(range, 52-80 years). Primary indication for intervention was disabling claudication in four patients, size of abdominal
aortic aneurysm in nine, and symptomatic aneurysm in one. Seven patients presented with a unilateral common iliac artery
(CIA) occlusion, four with a unilateral external iliac artery (EIA) occlusion, three with a unilateral combined CIA and
EIA occlusion, and one with bilateral CIA occlusions. Stents had been placed previously in two of the occluded CIAs
and in one of the occluded EIAs. Average length of the occluded segment was 7.5 cm (range, 2-17 cm). The occluded
CIAs and EIAs had mean diameters of 8.6 and 5.7 mm, respectively. Successful recanalization was achieved in 14 of the
15 vessels (93.3%). One EIA ruptured during recanalization but was easily controlled with a covered stent. A re-entry
device was used in two cases. Overall, 13 bifurcated devices were successfully implanted. Bilateral iliac occlusions in one
patient were recanalized. One Talent (Medtronic, Santa Rosa, Calif), eight Excluder (W. L. Gore and Associates,
Flagstaff, Ariz), and four Zenith (Cook Medical, Bloomington, Ind) devices were used. Mean length of stay was 2.3 days
(range, 1-6 days). No major perioperative complications or deaths occurred. During a mean follow-up of 28.2 months
(range, 1-86 months), there was 100% primary patency of successfully recanalized iliac arteries. Aneurysm sac size
decreased from a mean of 5.1 cm (range, 3.1-7.6 cm) preoperatively to 4.4 cm (range, 2.8-7.1 cm) at follow-up. No
aneurysms grew or ruptured. Three type II endoleaks occurred, one of which required coiling at 15 months. Two late
deaths occurred: one at 36 months secondary to complications from a coronary artery bypass graft/mitral valve
replacement and one at 34 months from a myocardial infarction.
Conclusions: The use of bifurcated endovascular devices after recanalization of an occluded iliac system is technically
feasible and durable at midterm follow-up. This technique re-establishes aortoiliac inflow to both lower extremities,
obviates the need for extra-anatomic bypass, and may preserve hypogastric perfusion in some patients. ( J Vasc Surg
2012;56:1549-54.)
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rysm repair (EVAR) by Parodi et al1 in 1991, there have
been many advances in the technology and ability to treat
abdominal aortic aneurysms (AAA) by endovascular means.
Concomitant aortoiliac occlusive disease (AIOD) still re-
mains a challenge to endograft implantation and may pre-
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atients with aortic aneurysm and significant iliac artery
tenosis or occlusion precluding placement of an endovas-
ular graft are considered to have TransAtlantic Inter-
ociety Consensus (TASC) D lesions, for which the TASC
I criteria recommend open repair.4 These patients often
xperience severe claudication and have significant comor-
idities that are associated with their peripheral arterial
isease, making them higher-risk candidates for open op-
rations.
Open surgical repair has been the traditional therapy in
atients with concomitant aneurysmal disease and AIOD.
owever, open surgical repair has been associated with
igher rates of perioperative morbidity and mortality. Hy-
rid strategies using iliac conduits have been used to pro-
ide patients with poor access an endovascular repair of
heir aneurysms.5 Conduit construction subjects the pa-
ient to a retroperitoneal incision and has been associated
ith higher complication rates and length of stay than in
atients whose repair is solely through femoral access.5 In
1549
Ri
a
m
i
f
r
e
w
(
s
o
h
c
7
o
(
v
C
O
c
Z
(
c
r
b
p
t
r
V
p
n
e
i
s
l
s
l
s
N
r
e
t
T
JOURNAL OF VASCULAR SURGERY
December 20121550 Vallabhaneni et alpatients with unilateral iliac occlusive disease and an AAA,
aortouniiliac (AUI) stent graft repair of the aneurysm with
crossover femorofemoral bypass graft (CFFB) is an alterna-
tive therapy. However, the results of these repairs are worse
compared with the outcomes of bifurcated stent grafts,
with decreased patency,6 added risk of femoral graft infec-
tion and occlusion, and a small risk for hemodynamically
significant steal of blood flow in the donor leg.7
Iliac recanalization of occlusive disease is common in
treatment of AIOD; however, this technique has never
been evaluated in patients with aneurysmal disease receiv-
ing a bifurcated EVAR. The aim of this study was to
evaluate short-term and midterm outcomes of bifurcated
EVAR in patients with aortic aneurysms and concomitant
chronic iliac occlusions requiring recanalization.
METHODS
Patients. A retrospective review of all patients who
underwent attempted iliac recanalization of chronic iliac
occlusions and concurrent EVAR of an infrarenal AAA was
performed at three academic tertiary referral centers be-
tween January 2004 and December 2010. Institutional
Review Board approval was obtained at each of the partic-
ipating institutions. Inclusion criteria included all patients
with iliac occlusions as well as aortic aneurysms in which an
EVAR with a bifurcated stent graft was attempted. The
analysis excluded patients with acute iliac thrombosis and
those with severely stenotic (but patent) iliac vessels.
We identified 14 patients with 15 occluded iliac arteries
in whom repair had been attempted. All patients were
evaluated preoperatively with computed tomography (CT)
imaging. Indications for repair included one of the follow-
ing: asymptomatic aneurysmal diameter; symptoms associ-
ated with the aortic aneurysm; or disabling claudication
with a concomitant aneurysm. Postoperative imaging sur-
veillance was CT angiograms at 1, 6, and 12months during
the first year and annually every year thereafter.
Anatomic and intraoperative variables recorded in-
cluded length of occlusion, size of iliac arteries, size of
aorta, adjunct procedures used, device used, and use of a
re-entry device. Variables recorded included perioperative
length of stay, perioperative complications, technical suc-
cess, death, and adjunct procedures. Length of follow-up,
secondary interventions, patency, and follow-up mortality
were also recorded.
Technique. All patients underwent a diagnostic an-
giogram of the occluded side. Iliac occlusions were crossed
by subintimal angioplasty or intraluminal recanalization
when possible. Re-entry devices were used according to the
surgeon’s preference. After angioplasty, the bifurcated
stent graft or additional stent was placed at the discretion of
the interventionalist. Devices approved by the U.S. Food
and Drug Administration were used in all procedures.
Statistical analysis. Statistical analysis was performed
using SigmaStat software (Systat Software Inc, Chicago,
Ill). Mean values are presented with ranges. TESULTS
During a 6-year period, 15 recanalizations of occluded
liac arteries were attempted for placement of bifurcated
ortic stent grafts in 14 patients (13 men; Table I). The
ean age was 67.8 years (range, 52-80 years). Primary
ndication for intervention was disabling claudication in
our patients, size of AAA in nine, and symptomatic aneu-
ysm in one. Seven patients (50%) presented with a unilat-
ral common iliac artery (CIA) occlusion, four (28.9%)
ith a unilateral external iliac artery (EIA) occlusion, three
21.4%) with a unilateral combined CIA and EIA occlu-
ion, and one (7.1%) with bilateral CIA occlusions. In two
f the occluded CIAs and one of the occluded EIAs, stents
ad been placed previously that had subsequently oc-
luded. Average length of the occluded iliac segment was
.5 cm (range, 2-17 cm). The mean diameters of the
ccluded CIAs and EIAs were 8.6 and 5.7 mm, respectively
Table II).
Successful recanalization was achieved in 14 of the 15
essels (93.3%; Fig). An Outback re-entry device (Cordis
orp, Warren, NJ) was used in two iliac arteries (13.3%).
verall, 13 bifurcated devices were implanted: eight Ex-
luder (W. L. Gore and Associates, Flagstaff, Ariz), four
enith (CookMedical, Bloomington, Ind), and one Talent
Medtronic, Santa Rosa, Calif). One technical failure oc-
urred in a patient with an occluded EIA stent, in which
ecanalization and re-entry into the true lumen could not
e accomplished. Subsequent treatment required the im-
lantation of a Cook Renu graft and CFFB.
Several adjunct procedures were performed during
hese cases to assist in completion (Table III). One EIA
uptured during recanalization but was controlled with a
iabahn (W. L. Gore & Associates) covered stent. One
atient had a severely calcified small but patent right exter-
al iliac artery and an occluded right hypogastric and left
xternal iliac artery. This patient received a right common
liac conduit for deployment of the main body given the
mall patent external iliac size on the right and a right-to-
eft iliofemoral bypass. His left EIA was crossed using
ubintimal angioplasty for deployment of the contralateral
eg to maintain pelvic perfusion through antegrade perfu-
ion of the patent left hypogastric artery.
The mean length of stay was 2.3 days (range, 1-6 days).
o deaths or major perioperative complications occurred
elated to recanalization of the iliac vessels. One patient had
vidence of distal embolization on postoperative day 5 on
he contralateral side to which his CIA was recanalized.
able I. Primary indication for operation
Indication No.
Size of aneurysm 9
Claudication 4
Symptomatic aneurysm 1
Total 14his was treated with an embolectomy.
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Volume 56, Number 6 Vallabhaneni et al 1551During a mean follow-up of 28.2 months (range, 1-86
months), there was 100% primary patency of successfully
recanalized iliac arteries. Aneurysm sac size decreased from
a preoperative mean of 5.1 cm (range, 3.1-7.6 cm) to 4.4
cm (range, 2.8-7.1 cm) at follow-up. No aneurysmal
growth or rupture occurred. All patients treated because of
severe claudication showed subjective improvement in their
symptoms at follow-up. Preoperative and postoperative
ankle-brachial indexes were obtained in two of the four
patients whose main indication was claudication. These
were 0.8 and 0.5 on the limb ipsilateral to the occlusion
preoperatively and improved to1 on the recanalized side
in both patients at follow-up. The claudication in the other
two patients improved, and they were asymptomatic post-
operatively.
Three patients received secondary interventions during
the follow-up period. One balloon angioplasty of a con-
tralateral Excluder limb for asymptomatic graft infolding
was performed at 3 months, and one patient received
subsequent renal and subclavian stent placement, which
were unrelated to their aneurysm. There were three type II
endoleaks, one of which required coiling at 15 months.
There was no evidence of graft occlusion. There were two
late deaths: one at 36 months secondary to complications
from a combined coronary artery bypass grafting andmitral
valve replacement operation and one at 34 months from a
myocardial infarction.
DISCUSSION
EVAR with a bifurcated device has largely replaced
open aortic aneurysm repair in patients due to lower peri-
operative morbidity and mortality as well as patient prefer-
ence. In 2007, up to 67% of all aortic aneurysms were
repaired by endovascular techniques.8 Some patients do
not have ideal anatomy for an EVAR, and up to 15.4% of
patients may undergo open aneurysm repair because of
access vessel size that is inadequate for delivery of a stent
graft.3
Options to open surgical repair in patients with aneu-
rysms and AIOD include placement of bifurcated en-
dografts after recanalization of the occlusion, AUI devices
with CFFB, or hybrid procedures with iliac conduits. In our
study, we evaluated patients with AAAs and chronic total
occlusions who underwent attempted treatment with an
endovascular modular bifurcated device at three tertiary
referral centers. We were successful in recanalizing all of the
lesions except for one (93.3%) in a woman who had under-
gone previous stent placement in her EIA. It is difficult to
determine if her previous occluded stent was a risk factor for
technical failure, especially because recanalization was pos-
sible in two other patients with occluded stents.
In our midterm follow-up of 28.2 months, we showed
100% iliac primary patency in patients receiving a bifurcated
EVAR and a recanalized iliac artery. This correlates with
studies showing good midterm to long-term outcomes of
bifurcated aortic stent grafts in off-label treatment of pa-
tients with TASC C and D AIOD and no aneurysmal
disease with favorable midterm outcomes.9,10 The use of a pifurcated device may prove to be more durable compared
ith traditional iliac stents in select patients with significant
IOD and TASC C and D lesions who are unable to
olerate open surgical repair.
AUI with CFFB has been shown to have decreased
rimary and secondary patency rates in patients with bifur-
ated aortic endografts.6 This has mostly been related to
ignificance of AIOD, with TASC C and D lesions being
he largest predictor of poor outcomes and increased mor-
idity.6
Crossover femorofemoral bypass has been shown to be
ffective, with higher patency rates when combined with
UI in aneurysmal disease than in occlusive disease, with
-year patency rates of90% touted in several studies.11-13
hese studies, however, included very few patients with
otal chronic occlusions, and many of the patients included
n these reports had undergone AUI graft placement before
ifurcated EVAR was available at their institution, thus
ncluding patients who did not necessarily have significant
eripheral vascular disease. In this study, we looked only at
atients with occluded iliac arteries and AAAs. These pa-
ients would likely not have as high a patency rate as the
revious studies of AUI and CFFB and would likely have
atency rates closer to 60% at 3 years, as shown in AIOD
tudies.14,15
There is also a decreased risk of graft infection from not
aving the extra-anatomic bypass in the groins and using a
ifurcated device. Graft infection develops in 2.6% to 5% of
atients undergoing CFFB11 and has been reported to lead
o death in some patients.11 The ability to repair the
atient’s aneurysm and restore inflow to a leg with a lower
isk of infection, as well as the higher patency, is an appeal-
ng argument for using recanalization of occluded iliac
rteries in bifurcated EVAR.
There are patients with aortic aneurysms, patent hypo-
astric arteries, and occluded ipsilateral external iliac arter-
es whowould benefit from recanalization and placement of
bifurcated endograft. If these patients received an AUI
evice with CFFB, they would lose perfusion of the hypo-
astric artery on the recipient side of the CFFB proximal to
he external iliac occlusion. Recanalization helps maintain
erfusion in these patients with patent hypogastric arteries
hat would otherwise be occluded. In four patients in our
tudy with isolated EIA occlusions, antegrade hypogastric
erfusion was maintained by recanalization of the occlu-
ion. The hypogastric artery may provide important collat-
ral blood supply to the intestines, spinal cord, and pelvic
rgans. Loss of important collaterals, especially in the face
f previous surgery, may increase the risk of mesenteric
schemia,16 paraplegia,17 thigh and buttock claudication,
nd pelvic ischemia.11 This may also be important if future
horacic aortic interventions are necessary to decrease the
isk of paraplegia from spinal ischemia by maintenance of
ollateral circulation.17
The two main issues that prevent patients with an
nfrarenal AAA from receiving EVAR are anatomy of the
roximal landing zone and vascular access.18 Significant
rogress has been made with respect to unfavorable infra-
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December 20121552 Vallabhaneni et alrenal necks, including the development of fenestrated and
branched endovascular devices. However, access issues still
remain quite a problem. Placement of a device may be
difficult in patients with small access vessels. Lower-profile
and more hydrophilic devices are being developed and are
undergoing trials to help with this problem and allow easier
passage of devices through difficult anatomy.
These devices, however, do not address the issue of
occluded iliac arteries. Iliac conduits are the most common
way that small blood vessels are bypassed for EVAR. Con-
duits may confer up to a 59% complication rate to the case,
mostly from the effect on the patient of the retroperitoneal
incision.5 It is commonly only used for delivery of the main
body of the bifurcated device. Recanalizing an occluded
vessel may allow placement of the bifurcated endografts
without a conduit.
One patient in our series needed a conduit because of a
small EIA that would not accommodate a device and had an
iliofemoral bypass to the side that was recanalized. This was
done because the patient had a small but patent EIA on the
side of the conduit and an occluded hypogastric artery on
Fig. Patient with symptomatic 4.6-cm symptomatic abd
lower left extremity. Left, Patient had occluded left co
Middle, Patient received a Gore Excluder device after su
with extension of a Viabahn stent graft into the left exte
widely patent left iliac system. This remains patent at 22
Table II. Patient perioperative characteristics
Variable 1 2
AAA size, cm 4 4.6
Operative indication Severe claudicant Symptomatic AAA
Device Excluder Excluder
Iliacs recanalized, No. 1 1
Occluded vessels R CIA L CIA, L EIA
Previous stent No No
Occlusion length, cm 4 13
LOS, days 2 4
Technical success Yes Yes
AAA, Abdominal aortic aneurysm; B/L, bilateral; CIA, common iliac arterythat side as well. On the side contralateral to the conduit, ihere was a very diseased EIA that was occluded extending
o the femoral artery. Because the patient had already
eceived the conduit, we used it to help maintain hypogas-
ric perfusion after recanalization of the occluded EIA and
elivery of the device.
One of the potential complications of recanalizing
mall, calcified tortuous vessels is the possibility of rupture
f the iliac artery. Angioplasty of stenotic calcified arteries
as been reported to have a 1% risk of rupture in large
eries.19 Covered stent graft insertion to treat this compli-
ation has met with good success but can prove fatal if wire
ccess is lost. Recanalization of chronic total iliac occlusions
as been reported, with a risk of rupture in 1.4% of cases.20
nly one rupture occurred in our series, and we were able
o treat this with a covered stent graft, with minimal added
orbidity.
Preoperative planning is very important in these com-
lex cases. Three-dimensional imaging with centerline of
ow measurements of vessel diameters is important to
etermine if the size of the native iliac arteries can accom-
odate a bifurcated device. Typically, the more diseased
al aortic aneurysm (AAA) and disabling claudication in
n iliac, left external iliac and left hypogastric arteries.
al angioplasty and recanalization of the left iliac system
iac artery. Right, Completion angiogram demonstrates
ths of follow-up.
Patients
3 4 5 6 7
4.5 5.7 7.3 5 5
ere claudicant AAA size AAA size AAA size AAA size
luder Excluder Excluder Zenith Talent
1 1 2 1 1
IA, L EIA L EIA B/L CIA L EIA R CIA
No No No No
17 9 6/2 10 2
2 2 2 2 2
Yes Yes Yes Yes
, external iliac artery; L, left; LOS, length of stay; R, right.omin
mmo
bintim
rnal ilSev
Exc
L C
No
Yesliac artery with the occlusion is used to deliver the con-
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deliver the device. The smallest diameter device should be
used to effectively exclude the aneurysm.
These patients typically also have severe comorbidities
and may not be good candidates for open repair. Preoper-
ative counseling with the patients should describe potential
alternative procedures if there is a technical failure, includ-
ing AUI CFFB as well as possible conversion to open
surgical repair. A full range of adjunctive equipment should
be available for the case, including AUI devices, a full range
of balloons, and bare-metal and covered stent grafts in case
of iliac rupture. Re-entry devices may be useful if the true
lumen cannot be re-entered during recanalization.
This study has several limitations. This retrospective
nonrandomized study looked at patients who were oper-
ated on with intent to perform endovascular recanalization
of these occlusions. Patients with aortoiliac occlusions that
were not anatomically suitable for this procedure were
potentially seen at the three institutions, so there was a
potential for selection bias. We did not evaluate patients
with aneurysms and iliac artery occlusions that were treated
by more traditional means such as open aortic surgery or
AUI and CFFB. We also did not include patients with
severe stenosis, although these patients may potentially also
be treated with adjunctive angioplasty, sequential dilation
or stenting of the arteries, or both.
This was also a relatively small study, with only 14
patients garnered from three tertiary referral centers during
a 6-year period. Larger studies with longer follow-up as-
sessments of this method would be needed to determine
Table II. Continued.
8 9 10
4 3.1 5.1
Severe claudicant Severe claudicant AAA size
Excluder Excluder Excluder
1 1 1
L CIA R CIA L CIA
Yes Yes No
4 4 6
1 2 1
Yes Yes Yes
Table III. Adjunct procedures
Procedure No.
Covered stent graft in EIA 2
Iliofemoral endarterectomy 2
Bare stent in EIA 1
Extension to EIA 1
Re-entry device used 2
Right iliac conduit iliofemoral bypass contralateral side 1
EIA, External iliac artery.the long-term outcomes of these patients.ONCLUSIONS
Use of a bifurcated EVAR to treat patients with con-
omitant infrarenal aortic aneurysms and chronic total oc-
lusions of the iliac arteries is feasible, with a high rate of
echnical success, and is effective, with good midterm pa-
ency and aneurysm sac regression in selected patients.
arger long-term studies are needed to prove that this is an
ffective and durable treatment strategy for patients with
neurysmal and occlusive disease.
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Dr Samuel Money (Scottsdale, Ariz). I thank the authors for
sending me a copy of their manuscript well before this meeting.
The manuscript by Vallabhaneni and coauthors describes recana-
lizing chronic occlusions of the iliac system to facilitate placement
of devices for endovascular aneurysm repair (EVAR). It is quite an
interesting paper and quite an interesting concept. I have numer-
ous questions. My first question regards the actual incidence of this
occurring. You describe 14 patients at three very busy tertiary care
institutions over a 7-year period. How many total EVARs were
performed at these institutions, and how many were turned down?
You talk about 14 patients. Are we talking 1% of the total popula-
tion with abdominal aortic aneurysm (AAA) population, 2%, or
10%? It seems to me that this is a very, very small percentage of
patients; however, I would ask you to just sort of share with us what
percentage you really think this would be.
Another question: What was the mean size of your AAAs? You
describe a range from 3.1 to 7.6 with a mean of 5.1 cm. Clearly,
these are smaller aneurysms than one would expect; however, I
believe some patients were treated because of their occlusive dis-
ease. Can you please delineate on the fact that your average
aneurysm size was 5.1 cm?
You discuss one patient who had a ruptured external iliac. As
salvage for the bleeding you placed a covered stent. Did you then
have enough diameter to pass the endograft up with the Viabahn in
place? Or, did you place the endograft while there was still some
oozing and then place the Viabahn? My guess is you probably used
this as the contralateral limb, is this so?
My next question involves the use of additional bare-metal
stents. Did you use these? Frequently, when we place an endograft,
it lays in an area of unusual tortuosity or in an area of such severe
calcification that ballooning just does not help. We found that we
have probably reduced our iliac limb occlusions by placing a
self-expanding stent and sort of smoothing out the abrupt angu-
lation. I was wondering if you used any bare-metal stents in these
cases?
My final question complements you on this superb paper andeed what we call “touch-up procedures?” Thank you very much.
appreciate discussing this paper.
Dr Ehab E. Sorial. Thank you. In reference to the first
uestion, the actual incidence or the occurrence of this iliac occlu-
ion in the setting of aortic aneurysm is based on our institution,
he University of Kentucky. I would say we do approximately 70
VARs a year. It is hard to basically say how many of them had
ccluded iliacs. One of the flaws of the study is that we did not
dentify all patients who had iliac occlusions receiving open or
ndovascular repair. It was not a randomized trial. All that we
ooked at were patients who had iliac occlusions and aneurysms
ho underwent EVAR placement. So I would guess the range is
bout 2% to 5% to have the iliac occlusion and the aneurysm at the
ame time, but that is a guess.
In reference to the second question, most of these patients
nderwent EVAR placement for an aneurysm size5 cm. The few
atients that underwent aneurysm repair 5 cm are because of
laudication symptoms or because of their aneurysm being symp-
omatic.
The third question was regarding the iliac rupture that re-
uired placement of an external iliac Viabahn stent. The ruptured
liac in this patient happened after recanalizing his left side and after
lacement of main body of the aortic graft from the right side.
asically, trying to dilate the left external iliac with a bigger balloon
s when it ruptured. So the Viabahn stent was placed and extended
o the contralateral gate so at that time we already had the main
ody of the aortic graft placed from the contralateral side.
Regarding the use of bare-metal stents, we use them occasion-
lly for the distal part of the iliac limb at the tortuosity area just to
ack the graft down so that it does not begin “bird’s beaking” or
ust does not lift up, but in those patients, we used them just
ecause of the occlusive disease the patient had.
Successful long-term results? I speculate that possibly it will be
good option for a lot of patients, especially if we can recanalize
he iliacs. We have just a few years of follow-up on those patients,
ut I expect it is going to be a successful long-term outcome for
hese patients. Thank you.
